BMF-650 preclinical shows 12-15% weight loss in obese monkeys; IND on track H2 2025

Biomea Fusion, Inc.

28-day study in 15 obese cynomolgus monkeys; oral BMF-650 at 10 or 30 mg/kg daily.
Weight loss of 12% (10 mg/kg) and 15% (30 mg/kg) from baseline at Day 28.
Daily food intake reduced to 35g (10 mg/kg) and 16g (30 mg/kg) vs 109g for vehicle.
IND submission for BMF-650 on track for second half of 2025.
Full preclinical data set planned for upcoming medical conference presentation.

item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.